Oxalic Acid

Oxalic Acid

SCHEMBL352319

O=C(O)C(=O)O.OC[C@H]1CNCCO1

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC6A4 known ✓ P31645 12/20 0.36
SLC6A2 P23975 15/20 0.36
SLC6A3 Q01959 10/20 0.36
ADRB2 P07550 1/20 0.36
HTR1A P08908 1/20 0.36
HTR2A P28223 1/20 0.36
ADRA1A P35348 1/20 0.36
HTR2B P41595 1/20 0.36
ADRA2C P18825 1/20 0.36
CHEK1 O14757 1/20 0.34
SLC6A1 P30531 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRB2 P47870 1/20 0.33
SLC6A12 P48065 1/20 0.33
SLC6A11 P48066 1/20 0.33
SLC6A13 Q9NSD5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL351294 1.00 SLC6A2 (0.36) SLC6A2SLC6A4SLC6A3ADRB2HTR1A
SCHEMBL619548 0.90
SCHEMBL17137 0.90
SCHEMBL554471 0.90
Hydrochloric Acid SCHEMBL15573075 0.88
Hydrochloric Acid SCHEMBL16333974 0.88
Hydrochloric Acid SCHEMBL352613 0.88
Fumaric Acid SCHEMBL353035 0.87 SLC6A2 (0.38) SLC6A2SLC6A4SLC6A3ADRB2HTR1A
Maleic Acid SCHEMBL352365 0.87 SLC6A2 (0.38) SLC6A2SLC6A4SLC6A3ADRB2HTR1A
Fumaric Acid SCHEMBL351291 0.87 SLC6A2 (0.38) SLC6A2SLC6A4SLC6A3ADRB2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8648190-B2 Process for producing 2-hydroxymethylmorpholine salt DAISO CO., LTD. (JP) 2014-02-11 US disclosed
EP-2388252-B1 PROCESS FOR PRODUCING 2-HYDROXYMETHYLMORPHOLINE SALT DAISO CO LTD (JP) 2013-07-24 EP disclosed
US-20120016120-A1 PROCESS FOR PRODUCING 2-HYDROXYMETHYLMORPHOLINE SALT DAISO CO., LTD. (JP) 2012-01-19 US disclosed
EP-2388252-A1 PROCESS FOR PRODUCING 2-HYDROXYMETHYLMORPHOLINE SALT Daiso Co., Ltd. (JP) 2011-11-23 EP disclosed
US-8040010-B2 Permanent magnet type generator and hybrid vehicle using the same HITACHI, LTD. (JP) 2011-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120016120-A1 PROCESS FOR PRODUCING 2-HYDROXYMETHYLMORPHOLINE SALT THOP1, AVPR2, HPD SLC6A4 111/4885SLC6A2 77/4885SLC6A3 206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.